Dkk1 blocks Wnt-induced osteoprotegerin production in osteoblast progenitors in multiple myeloma

被引：0
|
作者：
Qiang, Y.
Chen, Y.
Brown, N.
Rudikoff, S.
Barlogie, B.
Shaughnessy, J. D., Jr.
机构：
[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[2] NCI, Cellular & Mol Biol Lab, Bethesda, MD 20892 USA
来源：
BONE | 2007年 / 40卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [1] DKK1 in multiple myeloma
    Lu, CM
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14): : 1465 - 1465
  • [2] On the molecular mechanism of DKK1 inhibition of osteoblast differentiation in multiple myeloma.
    Qiang, Ya-Wei
    Chen, Yu
    Stephens, Owen
    Rubin, Jeff
    Rudikoff, Stuart
    Barlogie, Bart
    Shaughnessy, John D., Jr.
    BLOOD, 2006, 108 (11) : 979A - 979A
  • [3] Epigenetic silencing of the WNT antagonist dickkopf-1(DKK1) in multiple myeloma
    Kocemba, K. A.
    Groen, R. W.
    Kersten, M. J.
    Bloem, A. C.
    Lokhorst, H. M.
    Spaargaren, M.
    Pals, S. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 117 - 117
  • [4] Dkk1 disrups Wnt signaling regulated Opg/rankl axis in osteoblast progenitors, a potential mechanism of myeloma triggered osteolytic bone lesion
    Qiang, Y.
    Brown, N.
    Chen, Y.
    Barlogie, B.
    Shaughnessy, J., Jr.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 63 - 63
  • [5] Serum DKK1 Levels in Multiple Myeloma
    Mitsiades, C.
    Richardson, P. G.
    Grant, S.
    Pei, X-Y
    Berenson, J. R.
    Richon, V.
    Garcia-Vargas, J.
    Rizvi, S.
    Anderson, K. C.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S117 - S117
  • [6] SERUM DKK1 IN SMOLDERING MULTIPLE MYELOMA
    Hernandez-Martin, M.
    Fisac Herrero, R. M.
    Olivier Cornacchia, C.
    Tajada, P.
    Moro, M. J.
    Cuello, R.
    Martin Garcia-Sancho, A.
    Aguilera, C.
    Garcia-Frade, J.
    Lopez, L.
    Casadomartin, T.
    Miguel, J. F. San
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 387 - 388
  • [7] SERUM DKK1 IN MULTIPLE MYELOMA PATIENTS
    Heider, U.
    Kaiser, M.
    Mieth, M.
    Rademacher, J.
    Lamottke, B.
    Jakob, C.
    Braendle, E.
    Stover, D.
    Sezer, O.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 159 - 159
  • [8] The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
    Tian, E
    Zhan, FH
    Walker, R
    Rasmussen, E
    Ma, YP
    Barlogie, B
    Shaughnessy, JD
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26): : 2483 - 2494
  • [9] Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma
    Qiang, Ya-Wei
    Barlogie, Bart
    Rudikoff, Stuart
    Shaughnessy, John D., Jr.
    BONE, 2008, 42 (04) : 669 - 680
  • [10] DKK1 and sclerostin are early markers of relapse in multiple myeloma
    Mabille, Charlotte
    Ruyssen-Witrand, Adeline
    Degboe, Yannick
    Gennero, Isabelle
    Avet-Loiseau, Herve
    Roussel, Murielle
    Hebraud, Benjamin
    Nigon, Delphine
    Attal, Michel
    Laroche, Michel
    BONE, 2018, 113 : 114 - 117
12345